Cambridge, Massachusetts-based clinical biotech firm City Therapeutics has set terms for its upcoming initial public offering on the NASDAQ under…

San Diego-based biotechnology firm ADARx Pharmaceuticals, Inc. has officially priced its upsized initial public offering (IPO) at $17.00 per share—the…
As artificial intelligence models expand and hyper-scaler data centers push electrical grids to their limit, one critical industry has emerged…
Sign in to your account